Advanced search
Publication Cover
Leukemia & Lymphoma Volume 53, 2012 - Issue 12
Submit an article Journal homepage
244
Views
15
CrossRef citations to date
0
Altmetric
Letter

Bortezomib and dexamethasone as first-line therapy for a patient with newly diagnosed polyneuropathy, organomegaly, endocrinopathy, M protein and skin changes syndrome complicated by renal failure

Jian LiDepartment of Hematology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People's Republic of China
,
Wei ZhangDepartment of Hematology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People's Republic of China
,
Wen-Ying KangDepartment of Hematology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People's Republic of China
,
Xin-Xin CaoDepartment of Hematology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People's Republic of China
,
Ming-Hui DuanDepartment of Hematology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People's Republic of China
&
Dao-Bin ZhouDepartment of Hematology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People's Republic of ChinaCorrespondence[email protected]
Pages 2527-2529 | Received 19 Apr 2012, Accepted 30 Apr 2012, Published online: 12 Jun 2012

References

  • Dispenzieri A. POEMS syndrome: 2011 update on diagnosis, risk-stratification, and management. Am J Hematol 2011;86:591–601.
  • Li J, Zhou DB, Huang Z, . Clinical characteristics and long-term outcome of patients with POEMS syndrome in China. Ann Hematol 2011;90:819–826.
  • Dispenzieri A, Moreno-Aspitia A, Suarez GA, . Peripheral blood stem cell transplantation in 16 patients with POEMS syndrome, and a review of the literature. Blood 2004;104:3400–3407.
  • Li J, Zhang W, Li J, . Combination of melphalan and dexamethasone for patients with newly diagnosed POEMS syndrome. Blood 2011;117:6445–6449.
  • Tang X, Shi X, Sun A, . Successful bortezomib-based treatment in POEMS syndrome. Eur J Haematol 2009;83:609–610.
  • Kaygusuz I, Tezcan H, Cetiner M, . Bortezomib: a new therapeutic option for POEMS syndrome. Eur J Haematol 2010;84:175–177.
  • Ohguchi H, Ohba R, Onishi Y, . Successful treatment with bortezomib and thalidomide for POEMS syndrome. Ann Hematol 2011;90:1113–1114.
  • Sobas MA, Alonso Vence N, Diaz Arias J, . Efficacy of bortezomib in refractory form of multicentric Castleman disease associated to poems syndrome (MCD-POEMS variant). Ann Hematol 2010;89:217–219.
  • Wang X, Ye S, Xiong C, . Successful treatment with bortezomib and thalidomide for POEMS syndrome associated with multicentric mixed-type Castleman's disease. Jpn J Clin Oncol 2011;41:1221–1224.
  • Warsame R, Kohut IE, Dispenzieri A. Successful use of cyclophosphamide, bortezomib, and dexamethasone to treat a case of relapsed POEMS. Eur J Haematol 2012 Mar 14. [Epub ahead of print]
  • Graham RC, Hughes R. A modified peripheral neuropathy scale: the Overall Neuropathy Limitations Scale. J Neurol Neurosurg Psychiatry 2006;77:973–976.
  • Nakamoto Y, Imai H, Yasuda T, . A spectrum of clinicopathological features of nephropathy associated with POEMS syndrome. Nephrol Dial Transplant 1999;14:2370–2378.
  • Nakagawa T, Tanabe K, Croker BP, . Endothelial dysfunction as a potential contributor in diabetic nephropathy. Nat Rev Nephrol 2011;7:36–44.
  • Dispenzieri A, Kyle RA, Lacy MQ, . POEMS syndrome: definitions and long-term outcome. Blood 2003;101:2496–2506.
  • San-Miguel JF, Richardson PG, Sonneveld P, . Efficacy and safety of bortezomib in patients with renal impairment: results from the APEX phase 3 study. Leukemia 2008;22:842–849.
  • Argyriou AA, Iconomou G, Kalofonos HP. Bortezomib-induced peripheral neuropathy in multiple myeloma: a comprehensive review of the literature. Blood 2008;112:1593–1599.
  • Bringhen S, Larocca A, Rossi D, . Efficacy and safety of once-weekly bortezomib in multiple myeloma patients. Blood 2010;116: 4745–4753.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.